Evidence map›Paper›PMID 36843130›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2023

Mood and behavior regulation: interaction of lithium and dopaminergic system.

Marjan Mohamadian, Hamed Fallah, Zahra Ghofrani-Jahromi, Mehrsa Rahimi-Danesh, Mohammad-Saleh Shokouhi Qare Saadlou, Salar Vaseghi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Mechanisms of Lithium Action: The Old and New Findings.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Dopamine Pharmacodynamics: New Insights.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Local Thyroid Hormone Action in Brain Development.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Marjan MohamadianAmerican Psychological Association, Worcester, MA, USA.
Hamed FallahDepartment of Basic Sciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Zahra Ghofrani-JahromiCognitive Neuroscience Lab, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Mehrsa Rahimi-DaneshCognitive Neuroscience Lab, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran.
Mohammad-Saleh Shokouhi Qare SaadlouDepartment of Psychology, Faculty of Humanities, Sirjan Branch, Islamic Azad University, Sirjan, Iran.
Salar VaseghiCognitive Neuroscience Lab, Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran. vaseghi@imp.ac.ir.
Academic Center for Education, Culture and Research · IRAmerican Psychological Association · USIslamic Azad University, Sirjan Branch · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lithium is one of the most effect mood-stabilizing drugs prescribed especially for bipolar disorder. Lithium has wide range effects on different molecular factors and neural transmission including dopaminergic signaling. On the other hand, mesolimbic and mesocortical dopaminergic signaling is significantly involved in the pathophysiology of neuropsychiatric disorders. This review article aims to study lithium therapeutic mechanisms, dopaminergic signaling, and the interaction of lithium and dopamine. We concluded that acute and chronic lithium treatments often reduce dopamine synthesis and level in the brain. However, some studies have reported conflicting results following lithium treatment, especially chronic treatment. The dosage, duration, and type of lithium administration, and the brain region selected for measuring dopamine level were not significant differences in different chronic treatments used in previous studies. It was suggested that lithium has various mechanisms affecting dopaminergic signaling and mood, and that many molecular factors can be involved, including brain-derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB), β-catenin, protein kinase B (Akt), and glycogen synthase kinase-3 beta (GSK-3β). Thus, molecular effects of lithium can be the most important mechanisms of lithium that also alter neural transmissions including dopaminergic signaling in mesolimbic and mesocortical pathways.

Indexed as

Bipolar DisorderLithiumDopamineGlycogen Synthase Kinase 3 betaHumansSignal TransductionDopamineGlycogen Synthase Kinase 3 betaLithiumAcute treatmentChronic treatmentDopamineLithiumMoodNeural transmission

Identifiers

PMID36843130
OpenAlexW4322207891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.